In the T2DM group, 6 were on insulin, 6 were on metformin, 1 on lipid-lowering agents, 2 on ACE inhibitors, 3 on beta-blocker I, 1 on diuretics and 3 on angiotensin II. The gene discussed is INS; the disease is type 2 diabetes mellitus.